Internet Content & Information
Compare Stocks
5 / 10Stock Comparison
ONFO vs HIMS vs DCOM vs TDOC vs SI
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Equipment & Services
Banks - Regional
Medical - Healthcare Information Services
Medical - Specialties
ONFO vs HIMS vs DCOM vs TDOC vs SI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Internet Content & Information | Medical - Equipment & Services | Banks - Regional | Medical - Healthcare Information Services | Medical - Specialties |
| Market Cap | $6M | $5.50B | $1.61B | $1.22B | $275M |
| Revenue (TTM) | $11M | $2.37B | $730M | $2.51B | $32M |
| Net Income (TTM) | $-2M | $-13M | $111M | $-171M | $-16M |
| Gross Margin | 60.3% | 71.7% | 56.1% | 65.6% | 77.0% |
| Operating Margin | -19.7% | -1.3% | 21.5% | -7.6% | -46.3% |
| Forward P/E | — | 51.6x | 10.5x | — | — |
| Total Debt | $3M | $1.26B | $371M | $1.04B | $15M |
| Cash & Equiv. | $477K | $229M | $2.35B | $781M | $6M |
ONFO vs HIMS vs DCOM vs TDOC vs SI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 22 | May 26 | Return |
|---|---|---|---|
| Onfolio Holdings, I… (ONFO) | 100 | 62.4 | -37.6% |
| Hims & Hers Health,… (HIMS) | 100 | 393.6 | +293.6% |
| Dime Community Banc… (DCOM) | 100 | 117.1 | +17.1% |
| Teladoc Health, Inc. (TDOC) | 100 | 21.8 | -78.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ONFO vs HIMS vs DCOM vs TDOC vs SI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ONFO ranks third and is worth considering specifically for income & stability.
- Dividend streak 4 yrs, beta 1.45, yield 5.4%
- 5.4% yield, 4-year raise streak, vs DCOM's 2.7%, (3 stocks pay no dividend)
HIMS is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
- 155.4% 10Y total return vs DCOM's 64.6%
DCOM carries the broadest edge in this set and is the clearest fit for value and quality.
- Better valuation composite
- 15.2% margin vs SI's -49.4%
- +37.4% vs HIMS's -54.7%
- 0.8% ROA vs SI's -32.1%
Among these 5 stocks, TDOC doesn't own a clear edge in any measured category.
SI is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.77, current ratio 4.59x
- Beta 0.77, current ratio 4.59x
- 64.1% revenue growth vs TDOC's -1.5%
- Beta 0.77 vs HIMS's 2.48
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 64.1% revenue growth vs TDOC's -1.5% | |
| Value | Better valuation composite | |
| Quality / Margins | 15.2% margin vs SI's -49.4% | |
| Stability / Safety | Beta 0.77 vs HIMS's 2.48 | |
| Dividends | 5.4% yield, 4-year raise streak, vs DCOM's 2.7%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +37.4% vs HIMS's -54.7% | |
| Efficiency (ROA) | 0.8% ROA vs SI's -32.1% |
ONFO vs HIMS vs DCOM vs TDOC vs SI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
ONFO vs HIMS vs DCOM vs TDOC vs SI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DCOM leads in 3 of 6 categories
TDOC leads 1 • ONFO leads 1 • HIMS leads 0 • SI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DCOM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TDOC is the larger business by revenue, generating $2.5B annually — 223.7x ONFO's $11M. DCOM is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to SI's -49.4%. On growth, ONFO holds the edge at +36.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $11M | $2.4B | $730M | $2.5B | $32M |
| EBITDAEarnings before interest/tax | -$1M | $16M | $161M | $42M | — |
| Net IncomeAfter-tax profit | -$2M | -$13M | $111M | -$171M | — |
| Free Cash FlowCash after capex | -$1M | $82M | $182M | $251M | — |
| Gross MarginGross profit ÷ Revenue | +60.3% | +71.7% | +56.1% | +65.6% | +77.0% |
| Operating MarginEBIT ÷ Revenue | -19.7% | -1.3% | +21.5% | -7.6% | -46.3% |
| Net MarginNet income ÷ Revenue | -17.2% | -0.6% | +15.2% | -6.8% | -49.4% |
| FCF MarginFCF ÷ Revenue | -9.0% | +3.5% | +25.0% | +10.0% | -57.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +36.3% | +3.8% | — | -2.5% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -45.5% | -3.0% | +2.3% | +32.1% | — |
Valuation Metrics
TDOC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 15.4x trailing earnings, DCOM trades at a 69% valuation discount to HIMS's 49.1x P/E. On an enterprise value basis, TDOC's 14.8x EV/EBITDA is more attractive than HIMS's 40.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6M | $5.5B | $1.6B | $1.2B | $275M |
| Enterprise ValueMkt cap + debt − cash | $8M | $6.5B | -$371M | $1.5B | $284M |
| Trailing P/EPrice ÷ TTM EPS | -2.83x | 49.08x | 15.44x | -5.94x | -17.36x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 51.61x | 10.52x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.42x | — | — |
| EV / EBITDAEnterprise value multiple | — | 40.79x | -2.37x | 14.78x | — |
| Price / SalesMarket cap ÷ Revenue | 0.76x | 2.34x | 2.21x | 0.48x | 8.70x |
| Price / BookPrice ÷ Book value/share | 1.36x | 11.95x | 1.07x | 0.86x | — |
| Price / FCFMarket cap ÷ FCF | — | 74.30x | 8.84x | 4.28x | — |
Profitability & Efficiency
DCOM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DCOM delivers a 7.7% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-52 for ONFO. DCOM carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.34x. On the Piotroski fundamental quality scale (0–9), DCOM scores 8/9 vs ONFO's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -51.7% | -2.5% | +7.7% | -12.4% | — |
| ROA (TTM)Return on assets | -23.3% | -0.6% | +0.8% | -5.9% | -32.1% |
| ROICReturn on invested capital | -38.2% | +8.6% | +5.6% | -11.5% | — |
| ROCEReturn on capital employed | -51.5% | +9.4% | +6.1% | -10.0% | -34.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 8 | 6 | 3 |
| Debt / EquityFinancial leverage | 0.60x | 2.34x | 0.25x | 0.75x | — |
| Net DebtTotal debt minus cash | $2M | $1.0B | -$2.0B | $259M | $9M |
| Cash & Equiv.Liquid assets | $476,874 | $229M | $2.4B | $781M | $6M |
| Total DebtShort + long-term debt | $3M | $1.3B | $371M | $1.0B | $15M |
| Interest CoverageEBIT ÷ Interest expense | -6.65x | — | 0.57x | -8.76x | -11.13x |
Total Returns (Dividends Reinvested)
DCOM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $27,904 today (with dividends reinvested), compared to $483 for TDOC. Over the past 12 months, DCOM leads with a +37.4% total return vs HIMS's -54.7%. The 3-year compound annual growth rate (CAGR) favors DCOM at 35.9% vs TDOC's -34.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +54.7% | -25.1% | +24.2% | -4.0% | -7.0% |
| 1-Year ReturnPast 12 months | +10.5% | -54.7% | +37.4% | -7.9% | -11.2% |
| 3-Year ReturnCumulative with dividends | +2.7% | +131.5% | +150.8% | -72.2% | -11.2% |
| 5-Year ReturnCumulative with dividends | -51.7% | +179.0% | +26.7% | -95.2% | -11.2% |
| 10-Year ReturnCumulative with dividends | -51.7% | +155.4% | +64.6% | -38.8% | -11.2% |
| CAGR (3Y)Annualised 3-year return | +0.9% | +32.3% | +35.9% | -34.7% | -3.9% |
Risk & Volatility
Evenly matched — DCOM and SI each lead in 1 of 2 comparable metrics.
Risk & Volatility
SI is the less volatile stock with a 0.77 beta — it tends to amplify market swings less than HIMS's 2.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DCOM currently trades 96.6% from its 52-week high vs HIMS's 35.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.45x | 2.48x | 1.04x | 1.89x | 0.77x |
| 52-Week HighHighest price in past year | $2.48 | $70.43 | $37.90 | $9.77 | $17.94 |
| 52-Week LowLowest price in past year | $0.45 | $13.74 | $24.57 | $4.40 | $10.92 |
| % of 52W HighCurrent price vs 52-week peak | +46.8% | +35.5% | +96.6% | +69.3% | +74.5% |
| RSI (14)Momentum oscillator 0–100 | 54.6 | 60.1 | 55.9 | 68.2 | 46.3 |
| Avg Volume (50D)Average daily shares traded | 5.9M | 35.6M | 280K | 5.0M | 87K |
Analyst Outlook
ONFO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HIMS as "Hold", DCOM as "Hold", TDOC as "Hold", SI as "Buy". Consensus price targets imply 57.1% upside for SI (target: $21) vs 4.7% for HIMS (target: $26). For income investors, ONFO offers the higher dividend yield at 5.41% vs DCOM's 2.72%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $26.20 | $39.50 | $7.58 | $21.00 |
| # AnalystsCovering analysts | — | 19 | 10 | 42 | 3 |
| Dividend YieldAnnual dividend ÷ price | +5.4% | — | +2.7% | — | — |
| Dividend StreakConsecutive years of raises | 4 | — | 3 | — | — |
| Dividend / ShareAnnual DPS | $0.06 | — | $1.00 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.6% | 0.0% | 0.0% | 0.0% |
DCOM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TDOC leads in 1 (Valuation Metrics). 1 tied.
ONFO vs HIMS vs DCOM vs TDOC vs SI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ONFO or HIMS or DCOM or TDOC or SI a better buy right now?
For growth investors, SHOULDER INNOVATIONS, INC.
(SI) is the stronger pick with 64. 1% revenue growth year-over-year, versus -1. 5% for Teladoc Health, Inc. (TDOC). Dime Community Bancshares, Inc. (DCOM) offers the better valuation at 15. 4x trailing P/E (10. 5x forward), making it the more compelling value choice. Analysts rate SHOULDER INNOVATIONS, INC. (SI) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ONFO or HIMS or DCOM or TDOC or SI?
On trailing P/E, Dime Community Bancshares, Inc.
(DCOM) is the cheapest at 15. 4x versus Hims & Hers Health, Inc. at 49. 1x. On forward P/E, Dime Community Bancshares, Inc. is actually cheaper at 10. 5x.
03Which is the better long-term investment — ONFO or HIMS or DCOM or TDOC or SI?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +179. 0%, compared to -95. 2% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: HIMS returned +155. 4% versus ONFO's -51. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ONFO or HIMS or DCOM or TDOC or SI?
By beta (market sensitivity over 5 years), SHOULDER INNOVATIONS, INC.
(SI) is the lower-risk stock at 0. 77β versus Hims & Hers Health, Inc. 's 2. 48β — meaning HIMS is approximately 221% more volatile than SI relative to the S&P 500. On balance sheet safety, Dime Community Bancshares, Inc. (DCOM) carries a lower debt/equity ratio of 25% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ONFO or HIMS or DCOM or TDOC or SI?
By revenue growth (latest reported year), SHOULDER INNOVATIONS, INC.
(SI) is pulling ahead at 64. 1% versus -1. 5% for Teladoc Health, Inc. (TDOC). On earnings-per-share growth, the picture is similar: Dime Community Bancshares, Inc. grew EPS 330. 9% year-over-year, compared to -22. 2% for SHOULDER INNOVATIONS, INC.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ONFO or HIMS or DCOM or TDOC or SI?
Dime Community Bancshares, Inc.
(DCOM) is the more profitable company, earning 15. 2% net margin versus -49. 4% for SHOULDER INNOVATIONS, INC. — meaning it keeps 15. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DCOM leads at 21. 5% versus -46. 3% for SI. At the gross margin level — before operating expenses — SI leads at 77. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ONFO or HIMS or DCOM or TDOC or SI more undervalued right now?
On forward earnings alone, Dime Community Bancshares, Inc.
(DCOM) trades at 10. 5x forward P/E versus 51. 6x for Hims & Hers Health, Inc. — 41. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SI: 57. 1% to $21. 00.
08Which pays a better dividend — ONFO or HIMS or DCOM or TDOC or SI?
In this comparison, ONFO (5.
4% yield), DCOM (2. 7% yield) pay a dividend. HIMS, TDOC, SI do not pay a meaningful dividend and should not be held primarily for income.
09Is ONFO or HIMS or DCOM or TDOC or SI better for a retirement portfolio?
For long-horizon retirement investors, Dime Community Bancshares, Inc.
(DCOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 04), 2. 7% yield). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DCOM: +64. 6%, TDOC: -38. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ONFO and HIMS and DCOM and TDOC and SI?
These companies operate in different sectors (ONFO (Communication Services) and HIMS (Healthcare) and DCOM (Financial Services) and TDOC (Healthcare) and SI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ONFO is a small-cap high-growth stock; HIMS is a small-cap high-growth stock; DCOM is a small-cap deep-value stock; TDOC is a small-cap quality compounder stock; SI is a small-cap high-growth stock. ONFO, DCOM pay a dividend while HIMS, TDOC, SI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 18%
- Gross Margin > 36%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.